KarmelSonix appoints Viriathus to support OTC listing, to step up U.S. asthma … – Proactive Investors Australia


Proactive Investors Australia

KarmelSonix appoints Viriathus to support OTC listing, to step up U.S. asthma
Proactive Investors Australia
KarmelSonix focuses on supplying innovative, non-invasive acoustic tools for disease management of asthma and related pulmonary disorders. The company's product offerings afford KarmelSonix a unique opportunity to adopt a business model that combines

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.